1063146

Adare Pharmaceuticals, Inc. — FEI 1525864

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 11, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Vandalia, OH (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)